Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina, Fatemeh Akhlaghi
Drug Metabolism Reviews (2017) Vol. 49, Iss. 2, pp. 197-211
Open Access | Times Cited: 548

Showing 1-25 of 548 citing articles:

Apoptosis and necroptosis in the liver: a matter of life and death
Robert F. Schwabe, Tom Luedde
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 12, pp. 738-752
Open Access | Times Cited: 467
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Jinchunzi Yang, Marta Fernández‐Galilea, Leyre Martínez‐Fernández, et al.
Nutrients (2019) Vol. 11, Iss. 4, pp. 872-872
Open Access | Times Cited: 232
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Yamei Duan, Xiongfeng Pan, Jiayou Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 217
Changes in Glutathione Content in Liver Diseases: An Update
Mariapia Vairetti, Laura Giuseppina Di Pasqua, Marta Cagna, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 364-364
Open Access | Times Cited: 193
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
Estefanía de Gregorio, Anna Colell, Albert Morales, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3858-3858
Open Access | Times Cited: 140
Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
Françoise Stanke‐Labesque, Élodie Gautier-Veyret, Stéphanie Chhun, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107627-107627
Open Access | Times Cited: 140
As We Drink and Breathe: Adverse Health Effects of Microcystins and Other Harmful Algal Bloom Toxins in the Liver, Gut, Lungs and Beyond
Apurva Lad, Joshua D. Breidenbach, Robin C. Su, et al.
Life (2022) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 81
Antioxidant Peptides from Monkfish Swim Bladders: Ameliorating NAFLD In Vitro by Suppressing Lipid Accumulation and Oxidative Stress via Regulating AMPK/Nrf2 Pathway
Ming‐Feng Wu, Qing-Hao Xi, Sheng Yan, et al.
Marine Drugs (2023) Vol. 21, Iss. 6, pp. 360-360
Open Access | Times Cited: 77
Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions
Zedong Xiang, Huida Guan, Xiang Zhao, et al.
Food Research International (2024) Vol. 180, pp. 114068-114068
Closed Access | Times Cited: 40
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 35
MAFLD: Exploring the Systemic Effects Beyond Liver.
Utkarsh Dayal, Ujjwal Soni, Sourav Bansal, et al.
Journal of Community Hospital Internal Medicine Perspectives (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease
Jin Wang, Wanping He, Ping-Ju Tsai, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 113
Nutrition, inflammation and liver-spleen axis
Luigi Barrea, Carolina Di Somma, Giovanna Muscogiuri, et al.
Critical Reviews in Food Science and Nutrition (2017) Vol. 58, Iss. 18, pp. 3141-3158
Closed Access | Times Cited: 105
Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
José C. Fernández-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 935-959
Open Access | Times Cited: 91
A review of the pharmacology and toxicology of aucubin
Xiangchang Zeng, Fei Guo, Dongsheng Ouyang
Fitoterapia (2019) Vol. 140, pp. 104443-104443
Closed Access | Times Cited: 89
Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view
Fernando Bessone, Melisa Dirchwolf, María Agustina Rodil, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 48, Iss. 9, pp. 892-913
Open Access | Times Cited: 87
Aflatoxin B1 enhances pyroptosis of hepatocytes and activation of Kupffer cells to promote liver inflammatory injury via dephosphorylation of cyclooxygenase-2: an in vitro, ex vivo and in vivo study
Liyin Zhang, Deng-Lin Zhan, Yuanyuan Chen, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 11, pp. 3305-3320
Open Access | Times Cited: 86
Drug-induced liver injury in obesity and nonalcoholic fatty liver disease
Julien Allard, Dounia Le Guillou, Karima Begriche, et al.
Advances in pharmacology (2019), pp. 75-107
Open Access | Times Cited: 85
Lycopene prevents DEHP-induced hepatic oxidative stress damage by crosstalk between AHR–Nrf2 pathway
Yi Zhao, Rongkun Bao, Shi‐Yong Zhu, et al.
Environmental Pollution (2021) Vol. 285, pp. 117080-117080
Closed Access | Times Cited: 82
Animal and Organoid Models of Liver Fibrosis
Yulong Bao, Li Wang, Haiting Pan, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 78
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Veera Houttu, Susanne Csader, Max Nieuwdorp, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 72
Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
Chloe Wong, Ming Hui Lee, Clyve Yu Leon Yaow, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 65
Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism
Hidetoshi Nara, Rin Watanabe
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9889-9889
Open Access | Times Cited: 65
Single-nucleus RNA-seq2 reveals functional crosstalk between liver zonation and ploidy
Maria Lucia Richter, Ioannis K. Deligiannis, Kelvin Yin, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
Yeo‐Jung Kwon, Sangyun Shin, Young‐Jin Chun
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 63-83
Closed Access | Times Cited: 59
Page 1 - Next Page

Scroll to top